Skip to Content
Division of Medical Assistance and Health Services
Official Site of The State of New Jersey
Governor Mikie Sherrill • Lt. Governor Dr. Dale G. Caldwell
Translate
Translation Disclaimer
close
NJ.gov
Services
Agencies
FAQs
Frequently Asked Questions
Get Updates
close
Search
Search:
close
Department of Human Services
DHS
About
Department
Commissioner and Key Staff
Programs
COVID-19 Guidance
Health Care Services
Disability Programs
Family Programs
Social Services
Mental Health
Addiction Services
Aging Services
Housing
Divisions
Catastrophic Illness in Children Relief Fund (CICRF)
Commission for the Blind & Visually Impaired (CBVI)
Division of Aging Services (DoAS)
Division of the Deaf & Hard of Hearing (DDHH)
Division of Developmental Disabilities (DDD)
Division of Disability Services (DDS)
Division of Family Development (DFD)
Division of Medical Assistance & Health Services (DMAHS)
Division of Mental Health and Addiction Services (DMHAS)
Human Services Police
Office of Emergency Management (OEM)
Office of Legal and Regulatory Affairs
Office of New Americans
Office for Prevention of Developmental Disabilities
Office of Program Integrity & Accountability (OPIA)
Office of Contract Policy and Management
Notices
News
Press Releases 2026
2026
2025
2024
2023
2022
2021
2020
2019
2018
Videos 2026
2026
2025
2024
2023
2022
Videos with Audio Description
Publications
Get Involved
Public Advisory Boards, Commissions & Councils
Employment at DHS
Resources
Get Help
Language Access
Division of Medical Assistance and Health Services
Division of Medical Assistance and Health Services
Home
About DMAHS
Individuals & Families
Overview
NJ FamilyCare/Medicaid
Adults
Aged, Blind and Disabled
Children
Fully Integrated Dual Eligible Special Needs Plan
Health Care Services Covered by NJ FamilyCare
Medical Emergency Payment Program (MEPP)
NJ FamilyCare Health Plans
NJ WorkAbility
Pregnant Women
Transportation
Lead Poisoning Prevention
Federal Changes to NJ FamilyCare / Medicaid
Providers & Stakeholders
Overview
Provider Resources
NJ Medicaid & Managed Care
NJ FamilyCare Health Plans
Medical Assistance Customer Centers
Eligibility and Service Manuals
Medicaid Communications
Community Waiver
Public Notices
News, Publications, Reports & Resources
Overview
Publications
Monthly Enrollment Reports
Annual Fee-for-Service Prior Authorization Metrics
Division Staff & Contact Information
Meet the Director
General Information Numbers
Medical Assistance Customer Centers
E-mail Us
Public Advisory Boards, Commissions & Councils
Drug Utilization Review Board (DURB)
DURB Board Members
DURB Meeting Schedule & Minutes
DURB Annual Reports
DURB Educational Newsletters
DURB Approved Protocols
Medical Assistance Advisory Council
Beneficiary Advisory Council
Home
Public Advisory Boards, Commissions & Councils
Drug Utilization Review Board (DURB)
DURB Educational Newsletters
DURB Educational Newsletters
Collapse All
Expand All
March 2024
Updated Morphine Milligram Equivalents (MMEs)
October 2022
Oral Medications Used for COVID-19
June 2018
Metformin as First Line Treatment for Type 2 Diabetes
Morphine Milligram Equivalents (MME)
May 2017
Using Naloxone to Prevent Drug Overdose Deaths
December 2016
HIV Pre-Exposure Prophylaxis (PrEP)
April 2014
Treatment Options for Acute Pain
October 2013
Long-acting beta agonists in Asthma and COPD
June 2013
Vol. 01 No. 08: Treatment Options for Type 2 Diabetes
October 2011
Vol. 01 No. 07: Clinical News from the New Jersey Drug Utilization Review Board
Calendar Year 2009
Vol. 01 No. 01: Dental Prophylaxis Guidelines
Vol. 01 No. 02: Long Acting Beta-2 Agonists
Vol. 01 No. 03: Opportunistic Infections in Adults
Vol. 01 No. 04: Buprenorphine/Naloxone for Opioid Dependence Part 1
Vol. 01 No. 05: Buprenorphine/Naloxone for Opioid Dependence Part 2
February 2007
Drug Therapies for Insomnia
Osteoporosis
January 2007
Drug Utilization Review - Description of Pharmacy Edits
June 2006
The Appropriate Use of Proton-Pump Inhibitors and H2 Receptor Antagonists
Official Site of The State of New Jersey